Mingrong Qie
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Assessing the risk of undetected cervical cancer in women with a biopsy of high-grade cervical intraepithelial neoplasia: predictive value of cytology and endocervical curettage (ECC).
Journal: BMC cancer
Published: February 28, 2025
Rectal gastrointestinal stromal tumor with early liver metastasis misdiagnosed as vaginal wall tumor: a rare case report.
Journal: Frontiers in oncology
Published: February 05, 2025
Severe dorsolumbar pain following sacrocolpopexy in the absence of vertebral osteomyelitis or mesh exposure: A case report.
Journal: Asian journal of surgery
Published: October 06, 2024
Perivascular epithelioid cell tumor of the uterus and pelvic cavity.
Journal: Frontiers in oncology
Published: June 16, 2024
Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer.
Journal: Frontiers in oncology
Published: May 19, 2024
Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2.
Journal: Archives of biochemistry and biophysics
Published: January 03, 2024
Clinicopathologic characteristics, treatment, prognosis and pregnancy outcomes in rhabdomyosarcoma of the uterine cervix: a case series.
Journal: Ginekologia polska
Published: August 11, 2023
Successful pregnancy in a female with embryonal rhabdomyosarcoma of the cervix who received biopsy and chemotherapy alone without recurrence after 16 years: a case report and literature review.
Journal: BMC women's health
Published: July 01, 2023
Chinese expert consensus on the clinical applications of aminolevulinic acid-based photodynamic therapy in female lower genital tract diseases (2022).
Journal: Photodiagnosis and photodynamic therapy
Published: May 17, 2022
LncRNA MIR99AHG enhances adipocyte differentiation by targeting miR-29b-3p to upregulate PPARγ.
Journal: Molecular and cellular endocrinology
Published: December 13, 2021
MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC.
Journal: Annals of translational medicine
Published: February 11, 2021
miR-326 inhibits the cell proliferation and cancer stem cell-like property of cervical cancer in vitro and oncogenesis in vivo via targeting TCF4.
Journal: Annals of translational medicine
Published: January 25, 2021
Last Updated: 09/26/2026